Umbralisib tosylate
Umbralisib Tosylate (TGR-1202) is an orally active, dual inhibitor of PI3Kδ (EC50=22.2 nM) and CK1ε. It exhibits unique immunomodulatory effects on T-cells and is used in research for hematological malignancies, including in vitro and in vivo studies for chronic lymphocytic leukemia (CLL) .
Product Specifications
CAS Number
1532533-72-4
Field of Research
Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Smiles
S (=O) (=O) (O) C1=CC=C (C) C=C1.NC1=C2C (=NN ([C@@H] (C) C3=C (C (=O) C=4C (O3) =CC=C (F) C4) C5=CC (F) =CC=C5) C2=NC=N1) C6=CC (F) =C (OC (C) C) C=C6
Molecular Formula
C38H32F3N5O6S
Molecular Weight
743.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15138533 1 Vial
Lentiviral human PSMA6 shRNA (UAS) - Lentiviral human PSMA6 shRNA (UAS) (25)
Sign In for Pricing
View Details FPD80386-01 50 mg
2-{[ (9H-Fluoren-9-yl) methoxy]carbonyl}-8-oxa-2-azaspiro[4.5]decane-3-carboxylic acid
Sign In for Pricing
View Details FPD80386-02 0.5 g
2-{[ (9H-Fluoren-9-yl) methoxy]carbonyl}-8-oxa-2-azaspiro[4.5]decane-3-carboxylic acid
Sign In for Pricing
View Details